Origin of exhaled breath particles from healthy and human rhinovirus-infected subjects.

BACKGROUND Exhaled breath studies suggest that humans exhale fine particles during tidal breathing, but little is known of their physical origin in the respiratory system during health or disease. METHODS Particles generated by 3 healthy and 16 human rhinovirus (HRV)-infected subjects were counted using an optical particle counter with nominal diameter-size bins ranging between 0.3 and 10 μm. Data were collected from HRV-infected subjects during tidal breathing. In addition, data from healthy subjects were collected during coughs, swallows, tidal breathing, and breathing to total lung capacity (TLC) and residual volume (RV). Using general additive models, we graphed exhaled particle concentration versus airflow during exhalation. Exhaled particles were collected from expired air on gelatin filters and analyzed for HRV via quantitative PCR. RESULTS HRV-infected subjects exhaled from 0.1 to 7200 particles per liter of exhaled air during tidal breathing (geometric mean = 32 part/L). A small fraction (24%) of subjects exhaled most (81%) of the particles measured and 82% of particles detected were 0.300-0.499 μm. Minute ventilation, maximum airflow during exhalation, and forced expiratory volume 1 second (FEV(1) % predicted) were positively correlated with particle production. No human rhinovirus was detected in exhaled breath samples. Three healthy subjects exhaled less than 100 particles per liter of exhaled air during tidal breathing and increased particle concentrations more with exhalation to RV than with coughing, swallowing, or rapid exhalation. CONCLUSIONS Submicron particles were detected in the exhaled breath of healthy and HRV-infected subjects. Particle concentrations were correlated with airflow during the first half of exhalation, and peaked at the end of exhalation, indicating both lower and upper airways as particle sources. The effect of breathing maneuver suggested a major contribution from lower airways, probably the result of opening collapsed small airways and alveoli.

[1]  Benjamin J. Cowling,et al.  Influenza Virus in Human Exhaled Breath: An Observational Study , 2008, PloS one.

[2]  J. Grotberg,et al.  Flow-induced instabilities of a mucus–serous bilayer , 1999, Journal of Fluid Mechanics.

[3]  Q. Jöbsis,et al.  Exhaled breath condensate: a space odessey, where no one has gone before… , 2004, European Respiratory Journal.

[4]  W. Stanley.  THE SIZE OF INFLUENZA VIRUS , 1944, The Journal of experimental medicine.

[5]  Kerrie Mengersen,et al.  Size distribution and sites of origin of droplets expelled from the human respiratory tract during expiratory activities , 2009 .

[6]  M. King,et al.  Clearance of mucus by simulated cough. , 1985, Journal of applied physiology.

[7]  B. Coull,et al.  A Nonstationary Negative Binomial Time Series With Time-Dependent Covariates , 2006 .

[8]  Israel Rubinstein,et al.  Markers of inflammation in exhaled breath condensate of young healthy smokers. , 2004, Chest.

[9]  D. Milton,et al.  Risk of indoor airborne infection transmission estimated from carbon dioxide concentration. , 2003, Indoor air.

[10]  P. Barnes,et al.  Increased interleukin-4 and decreased interferon-gamma in exhaled breath condensate of children with asthma. , 2002, American journal of respiratory and critical care medicine.

[11]  Yangang Liu,et al.  THE EFFECT OF REFRACTIVE INDEX ON SIZE DISTRIBUTIONS AND LIGHT SCATTERING COEFFICIENTS DERIVED FROM OPTICAL PARTICLE COUNTERS , 2000 .

[12]  F. Hayden,et al.  Rhinoviruses: important respiratory pathogens. , 1998, Annals of medicine.

[13]  Q. Jöbsis,et al.  Childhood asthma: Exhaled markers of airway inflammation, asthma control score, and lung function tests , 2004, Pediatric pulmonology.

[14]  J. F. Stampfer,et al.  Particle concentration in exhaled breath. , 1987, American Industrial Hygiene Association journal.

[15]  M. Corradi,et al.  Chromium in exhaled breath condensate and pulmonary tissue of non-small cell lung cancer patients , 2008, International archives of occupational and environmental health.

[16]  P. Thomas,et al.  Relationship between Exhaled Breath Condensate Volume and Measurements of Lung Volumes , 2006, Respiration.

[17]  I. Orme,et al.  Cough-generated aerosols of Mycobacterium tuberculosis: a new method to study infectiousness. , 2004, American journal of respiratory and critical care medicine.

[18]  B. Oliver,et al.  A new method for sampling and detection of exhaled respiratory virus aerosols. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  W. Busse,et al.  Similar colds in subjects with allergic asthma and nonatopic subjects after inoculation with rhinovirus-16. , 2009, The Journal of allergy and clinical immunology.

[20]  O. Resta,et al.  Interleukin-6 is increased in breath condensate of patients with non-small cell lung cancer. , 2002, The International journal of biological markers.

[21]  Leonard B. Bacharier,et al.  Infectious triggers of asthma , 2005, Immunology and Allergy Clinics of North America.

[22]  S. Wood.  Modelling and smoothing parameter estimation with multiple quadratic penalties , 2000 .

[23]  P Fabian,et al.  Airborne influenza virus detection with four aerosol samplers using molecular and infectivity assays: considerations for a new infectious virus aerosol sampler. , 2009, Indoor air.

[24]  Wai-ming Lee,et al.  An optimized method to detect influenza virus and human rhinovirus from exhaled breath and the airborne environment. , 2009, Journal of environmental monitoring : JEM.

[25]  P. Apostoli,et al.  Exhaled metallic elements and serum pneumoproteins in asymptomatic smokers and patients with COPD or asthma. , 2006, Chest.

[26]  A. Hubbard,et al.  Toward Understanding the Risk of Secondary Airborne Infection: Emission of Respirable Pathogens , 2005, Journal of occupational and environmental hygiene.

[27]  C. Lam,et al.  Increased macrophage‐derived chemokine in exhaled breath condensate and plasma from children with asthma , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[28]  Lidia Morawska,et al.  The mechanism of breath aerosol formation. , 2009, Journal of aerosol medicine and pulmonary drug delivery.

[29]  B. Michalke,et al.  Comparison between exhaled breath condensate analysis as a marker for cobalt and tungsten exposure and biomonitoring in workers of a hard metal alloy processing plant , 2009, International archives of occupational and environmental health.

[30]  Gerhard Scheuch,et al.  Inhaling to mitigate exhaled bioaerosols. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[31]  F S Rosenthal,et al.  The size distribution of droplets in the exhaled breath of healthy human subjects. , 1997, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.